Published in Int J Prev Med on March 24, 2015
Impact of Probiotic Administration on Serum C-Reactive Protein Concentrations: Systematic Review and Meta-Analysis of Randomized Control Trials. Nutrients (2017) 0.77
Apolipoprotein A1 as a novel anti-implantation biomarker in polycystic ovary syndrome: A case-control study. J Res Med Sci (2015) 0.76
Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev (1997) 5.83
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod (2009) 3.74
Obesity and the human microbiome. Curr Opin Gastroenterol (2010) 3.38
A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab (1999) 3.24
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol (2011) 3.02
Use of probiotics in various diseases: evidence and promises. Pol Arch Med Wewn (2012) 2.07
Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res (2010) 1.99
Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod (2008) 1.95
Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition (2006) 1.92
Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. Br J Nutr (2008) 1.91
Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest (1995) 1.70
Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev (2010) 1.53
The gut microbiome as therapeutic target. Pharmacol Ther (2011) 1.40
Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J Intern Med (2010) 1.37
Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care (2012) 1.35
Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. World J Gastroenterol (2013) 1.22
Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut (2004) 1.15
The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci (2009) 1.14
Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis--a pilot study. Scand J Rheumatol (2003) 1.09
Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives. Atherosclerosis (2005) 1.07
Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age. Ann N Y Acad Sci (2006) 1.07
Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy. J Nutr (2010) 1.04
Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada. Curr Med Res Opin (2009) 1.03
The effects of probiotic and conventional yoghurt on lipid profile in women. Br J Nutr (2010) 1.01
Studying the human gut microbiota in the trans-omics era--focus on metagenomics and metabonomics. Curr Pharm Des (2009) 0.98
Polycystic ovary syndrome: update on diagnosis and treatment. Am J Med (2014) 0.94
Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab (2013) 0.93
Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia. Med J Aust (2012) 0.90
The effects of old, new and emerging medicines on metabolic aberrations in PCOS. Ther Adv Endocrinol Metab (2012) 0.89
Effects of daily consumption of probiotic yoghurt on inflammatory factors in pregnant women: a randomized controlled trial. Pak J Biol Sci (2011) 0.89
Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome. Wien Klin Wochenschr (2009) 0.87
The treatment of infertility in polycystic ovary syndrome: a brief update. Aust N Z J Obstet Gynaecol (2012) 0.84
Effects of probiotics in patients with diabetes mellitus type 2: study protocol for a randomized, double-blind, placebo-controlled trial. Trials (2013) 0.84
[Effect of viable Bifidobacterium supplement on the immune status and inflammatory response in patients undergoing resection for colorectal cancer]. Zhonghua Wei Chang Wai Ke Za Zhi (2010) 0.84
SPRING: an RCT study of probiotics in the prevention of gestational diabetes mellitus in overweight and obese women. BMC Pregnancy Childbirth (2013) 0.83
Epidemiology of polycystic ovary syndrome: a cross sectional study of university students at An-Najah national university-Palestine. Reprod Biol Endocrinol (2013) 0.82